Dopo l'orario di chiusura: 6.04 -0.03 -0.49%

Compass Pathways Plc Adr (CMPS)

Compass Pathways Plc Adr Borsa (CMPS) Ultime notizie

Compass Pathways Plc Adr (CMPS)

Compass Pathways Plc Adr Borsa (CMPS) Ultime notizie

Compass Pathways Plc ADR [CMPS] Insider Activity: An Update for Investors – Knox Daily - Knox Daily

Compass Pathways Plc ADR Inc. (CMPS) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Should You Buy the Dip on Compass Pathways Stock?

Compass Pathways Plc ADR (CMPS) Stock: A Year of Decreases and Increases - The InvestChronicle

Stock Surge: Compass Pathways Plc ADR (CMPS) Closes at 6.55, Marking a -5.62 Increase/Decrease – DWinneX - The Dwinnex

Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.

Selling Buzz: Compass Pathways Plc ADR [CMPS] 10% Owner Malievskaia Ekaterina sells 8900 shares of the ... - Knox Daily

Adversity is less terrifying than hope: Compass Pathways Plc ADR (CMPS) – Sete News - SETE News

Compass Pathways Plc ADR (CMPS) Stock: From Low to High in 52 Weeks - The InvestChronicle

Introducing Our Rant Against Compass Pathways Plc ADR – US Post News - US Post News

Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment - Investing.com India

Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By Investing.com - Investing.com

Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By Investing.com - Investing.com

A stock that deserves closer examination: Compass Pathways Plc ADR (CMPS) – US Post News - US Post News

Compass Pathways insider sells over $240k in company shares - Investing.com India

Compass Pathways exec sells over $246k in company stock - Investing.com India

Compass Pathways insider sells over $240k in company shares - Investing.com

Compass Pathways exec sells over $246k in company stock - Investing.com

Compass Pathways insider sells over $240k in company shares By Investing.com - Investing.com UK

Compass Pathways Plc ADR [CMPS] Insider Goldsmith George Jay sells 18762 Shares – Knox Daily - Knox Daily

Compass Pathways insider sells over $240k in company shares - Investing.com

These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring

Earnings call: COMPASS Pathways reports progress on COMP360 treatment - Investing.com

Earnings call: COMPASS Pathways reports progress on COMP360 treatment - Investing.com UK

Earnings call: COMPASS Pathways reports progress on COMP360 treatment - Investing.com

COMPASS Pathways PLC Sponsored ADR (CMPS) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo News UK

Investor's Toolkit: Key Ratios for Assessing Compass Pathways Plc ADR (CMPS)'s Performance – DWinneX - The Dwinnex

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Compass Pathways Plc ADR [CMPS] 10% Owner sales 10850 shares for $95307.0. – Knox Daily - Knox Daily

Compass Pathways executive sells shares worth over $490,000 By Investing.com - Investing.com

Compass Pathways insider sells over $490k in company stock - Investing.com

Compass Pathways insider sells over $490k in company stock By Investing.com - Investing.com

COMPASS Pathways PLC Sponsored ADR (CMPS) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Singapore News

Compass Pathways to announce first quarter financial results on May 8, 2024

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

The Attractiveness of Investing In Compass Pathways Plc ADR (CMPS) is Growing – Knox Daily - Knox Daily

The Attractiveness of Investing In Compass Pathways Plc ADR (CMPS) is Growing – Knox Daily - Knox Daily

Compass Pathways partners with Journey Clinical for psilocybin research - Investing.com

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

Post-Trade Analysis: Compass Pathways Plc ADR (CMPS) Slides -1.82, Closing at 8.10 – DWinneX - The Dwinnex

Post-Trade Analysis: Compass Pathways Plc ADR (CMPS) Slides -1.82, Closing at 8.10 – DWinneX - The Dwinnex

Compass Pathways insider sells over $460k in shares By Investing.com - Investing.com

Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference

Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday

Compass Pathways insider sells shares worth over $445k By Investing.com - Investing.com

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

Compass Pathways co-founders step down from board By Investing.com - Investing.com

Compass Pathways director sells over $700k in company stock By Investing.com - Investing.com

Simile a CMPS